Table of Contents

Mounjaro (Tirzepatide) is a new type of medication used to help manage type 2 diabetes by improving blood sugar control. Unlike other diabetes medications, Mounjaro is unique because it targets two key hormones influencing blood sugar and appetite. As a result, it has become an effective option for those struggling to maintain stable blood sugar levels, and for some, it can also support weight loss. However, like any medication, it’s essential to understand the potential side effects. In clinical trials, up to 22% of people experienced nausea, and around 10% reported vomiting.

Recently, Mounjaro has also been the subject of a lawsuit, where a patient claimed to have developed a severe condition known as gastroparesis, or “stomach paralysis,” after using the medication. This highlights the importance of being aware of both common and rare side effects. By being informed, patients can be better prepared to manage these effects and improve their experience with Mounjaro.

In this article, you will learn about the common and serious side effects of Mounjaro, how it impacts blood sugar, its effects on weight, and what to do if side effects occur. We will also explore the long-term safety of using Mounjaro to manage diabetes.

Key Takeaways

  • Mounjaro can cause common side effects like nausea (22% of patients), vomiting (10%), and diarrhea, but these usually go away after a few weeks as the body adjusts to the medication.
  • Serious side effects, such as pancreatitis, allergic reactions, and acute kidney injury, are rare but need immediate attention if symptoms like severe stomach pain or vomiting occur.
  • Mounjaro can lead to weight loss, with studies showing up to 12% weight reduction over 52 weeks, making it helpful for people with type 2 diabetes who struggle with weight management.
  • Some patients may experience low blood sugar (hypoglycemia), especially when Mounjaro is combined with insulin or sulfonylureas. Symptoms of hypoglycemia include shakiness, sweating, and confusion.
  • Long-term risks of using Mounjaro include potential kidney issues, cardiovascular risks, and persistent gastrointestinal problems. Regular monitoring is important to catch any issues early.
  • Thyroid C-cell tumors were observed in animal studies, so Mounjaro should be avoided by those with a family history of thyroid cancer or Multiple Endocrine Neoplasia syndrome type 2.

What Are the Common Side Effects of Mounjaro?

While Mounjaro is effective in controlling blood sugar, it can cause several common side effects, particularly in the early stages of treatment as the body adjusts to the medication. The most common side effects of Mounjaro include:

  • Nausea: This is one of the most frequently reported side effects, and it is believed to occur because the medication slows down stomach emptying. This can make patients feel full for longer periods, leading to discomfort or nausea.
  • Diarrhea: Diarrhea often happens due to changes in digestion, as Mounjaro impacts how the body processes food. It may be temporary and usually resolves as the body adapts to the medication.
  • Vomiting: Vomiting is often linked to nausea and can occur if the gastrointestinal system becomes overly irritated by the medication.
  • Decreased Appetite: Mounjaro can reduce appetite due to its effect on the stomach and digestion, which may also be part of why it promotes weight loss.

These side effects are usually mild and may lessen as the body gets used to the medication.

Can Mounjaro Cause Serious Side Effects?

While Mounjaro is generally well-tolerated, some patients have reported experiencing severe side effects, such as gastroparesis. This condition, also known as “stomach paralysis,” slows or stops the movement of food out of the stomach, leading to severe discomfort. In a recent lawsuit, a patient claimed to have lost 150 pounds using Mounjaro but alleged that the manufacturers did not adequately warn about the risk of developing gastroparesis. According to a report on Good Morning America (GMA), the patient experienced such severe symptoms that she required multiple emergency room visits.

ABC News medical contributor Dr. Darien Sutton commented on this issue, stating: “It is absolutely brutal. Patients often come in with severe dehydration and electrolyte abnormalities, and many have symptoms so difficult to control that they have to be admitted to the hospital” (Good Morning America).

Despite these reports, the manufacturers of Mounjaro, Eli Lilly, have stated that the medication has been extensively studied, with warnings about delayed gastric emptying included on the label. They actively monitor and report safety information to ensure patient safety.

Pancreatitis

One of the more serious side effects of Mounjaro is pancreatitis, an inflammation of the pancreas that requires immediate medical intervention. In clinical trials, pancreatitis occurred in 13 cases in the Mounjaro group versus 3 cases in the comparator-treated patients. The risk of pancreatitis, specifically in those with a history of pancreatitis, is unknown.

Symptoms of pancreatitis include serious stomach pain and vomiting. Experiencing symptoms indicative of pancreatitis, a serious Mounjaro side effect, should prompt immediate medical attention.

Allergy to medication

As with any drug, Mounjaro carries the risk of allergic reactions. Clinical trials have reported instances of allergy, with symptoms such as eczema and itching. Other GLP-1 agonists are associated with the risk of angioedema (swelling under the skin) and anaphylaxis, which can be serious and life-threatening. If you experience allergy symptoms, stop Mounjaro treatment, and if serious, seek medical attention immediately. For more mild allergy symptoms, still, contact your doctor as soon as possible.

Hypoglycemia

Hypoglycemia is an issue characterized by very low blood sugar levels. While antidiabetic treatment aims to lower blood sugar, we don’t want to do it so much that we deprive our bodies of energy. Sometimes, when we take several antidiabetic regimens at once, it can cause blood sugar levels to get too low. Thus, combining Mounjaro with insulin or insulin secretagogues (e.g., sulfonylureas) can increase your risk of hypoglycemia.

Your risk of hypoglycemia may be reduced by lowering the dose of your insulin or other antidiabetic medications. Your provider can help you do this if necessary. Additionally, you should be aware of the symptoms of hypoglycemia, which include shakiness, sweating, paleness, hunger, headache, abnormal heartbeat, nausea, drowsiness, anxiety, and irritability.

Acute kidney injury

Acute kidney injury (AKI) can occur in people using Mounjaro, especially if they are already at risk of kidney problems. AKI is a sudden loss of kidney function that can result in the build-up of waste products in the blood, leading to electrolyte imbalances and fluid overload. This can be life-threatening and may require dialysis or other interventions. It can manifest as symptoms like low urine output, drowsiness, swelling in your eyes, ankles, or legs, shortness of breath, nausea, chest pain, and confusion.

Case reports of individuals on other GLP-1 agonists have indicated AKI or chronic renal failure worsening, sometimes in those with underlying kidney disease. Thus, caution should be used when taking Mounjaro if you have kidney impairment and are experiencing serious GI problems.

Serious Gastrointestinal (GI) Disease

Mounjaro can exacerbate or lead to serious gastrointestinal diseases, particularly in people with a history of GI issues. These can include conditions such as severe gastroparesis (delayed stomach emptying) or intestinal obstructions. Symptoms may involve chronic nausea, vomiting, severe abdominal pain, and bloating. Patients with pre-existing gastrointestinal conditions may need to avoid using Mounjaro.

Acute gallbladder disease

Gallstones and mild inflammation characterize gallbladder disease, sometimes causing scarring and stiffness of the gallbladder. GLP-1 receptor agonists have been known to cause acute gallbladder disease events. With Mounjaro specifically, gallbladder issues occurred in 0.6 percent of patients on Mounjaro versus zero percent of patients treated with placebo. Gallbladder issues can present as symptoms such as nausea, gas, and stomach pain after meals.

Diabetic retinopathy

Diabetic retinopathy is an eye condition caused by damage to the blood vessels in the retina due to high blood sugar levels. Some studies suggest that rapid improvements in blood sugar control, as seen with Mounjaro, could potentially worsen this condition in the short term. This may lead to symptoms such as blurry vision, floaters, and, in severe cases, vision loss. Regular eye exams are recommended for patients on Mounjaro to monitor for any changes in eye health.

Thyroid C-cell tumors

Animal models evaluated how tirzepatide, Mounjaro’s main ingredient, affected rats throughout a two-year study. In rats, it was found that tirzepatide was correlated with an increased incidence of thyroid C-cell tumors. It is unclear to experts if Mounjaro does the same in humans. Because of this potential risk, Mounjaro should not be used in individuals who have a history or family history of Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) or medullary thyroid carcinoma (MTC).

If you are starting Mounjaro, it is important to be aware of the potential MTC risk. Additionally, you should be aware of thyroid tumor symptoms, including trouble swallowing, trouble breathing, neck masses, and persistent hoarseness. Otherwise, the need for additional monitoring procedures is uncertain.

How Does Mounjaro Impact Blood Sugar Levels?

Mounjaro works by enhancing the release of insulin in response to meals and lowering the production of glucagon (a hormone that raises blood sugar levels). By doing so, it helps maintain steady blood sugar levels throughout the day, particularly after eating.

However, there is a potential risk for hypoglycemia (low blood sugar), especially if Mounjaro is taken alongside other medications like insulin or sulfonylureas. Signs of hypoglycemia include dizziness, confusion, sweating, and feeling shaky. On the other hand, the risk of hyperglycemia (high blood sugar) is typically reduced with Mounjaro due to its dual-hormone action. Monitoring blood sugar levels regularly is essential to avoid these extremes.

Does Mounjaro Affect Weight Loss?

Understanding Mounjaro Side Effects and its Impact on Diabetes

Mounjaro has a unique impact on weight loss. It activates receptors that influence digestion and appetite, leading to a feeling of fullness and reduced food intake. Many patients report significant weight loss while taking the medication, with some studies showing an average weight reduction of up to 15% over a 72-week period. For patients with type 2 diabetes who are also struggling with weight management, this can be a beneficial side effect.

Interestingly, Mounjaro side effects for non-diabetics can also include weight loss. Although Mounjaro is approved for managing type 2 diabetes, some non-diabetic individuals using the medication off-label for weight management have reported similar outcomes. In clinical studies, non-diabetics experienced notable weight reduction, but this use is not officially approved, and the long-term effects for non-diabetic users are still being studied.

However, not all patients experience the same degree of weight loss, and some may not see any changes at all. It’s important to note that Mounjaro is not specifically approved for weight loss but rather for managing blood sugar in diabetes. Weight loss is considered a secondary benefit for many patients.

How Can You Manage Mounjaro Side Effects?

Mounjaro pen surrounded by healthy food and weights

Managing the side effects of Mounjaro, especially gastrointestinal (GI)-related symptoms like nausea, vomiting, and diarrhea, can help improve your experience with the medication. Here are practical tips to reduce the impact of these side effects:

Adjust Eating Habits

One of the most effective ways to reduce GI-related side effects is by modifying your eating patterns. Making small changes in your diet can prevent further irritation of the digestive system.

  • Eat smaller, more frequent meals to avoid overwhelming your digestive system.
  • Avoid high-fat, fried, or spicy foods, which can worsen nausea or vomiting.
  • Opt for bland foods like toast, crackers, or oatmeal when experiencing nausea.
  • Drink fluids slowly and throughout the day to stay hydrated, especially if diarrhea or vomiting occurs.

Medications to Help

In some cases, medications or supplements can help ease side effects. Choosing safe, non-prescription options that complement your Mounjaro treatment is important.

  • Over-the-counter antacids or medications to control nausea (like ginger supplements) can help reduce discomfort.
  • Stool softeners or fiber supplements may ease constipation if it develops. Always follow dosing instructions carefully.

Lifestyle Changes

Certain lifestyle habits can support your body’s adjustment to Mounjaro and minimize side effects. These simple adjustments can improve your overall comfort while taking the medication.

  • Stay active with light exercise, which can help stimulate digestion.
  • If recommended, gradually increasing your Mounjaro dosage can help your body adjust more comfortably to the medication.

Are There Any Long-Term Effects of Using Mounjaro for Diabetes?

Yes, there are potential long-term effects of using Mounjaro for diabetes. While Mounjaro can be effective in managing blood sugar levels, it’s important to be aware of the possible Mounjaro long-term side effects, which include:

  • Cardiovascular Risks: Long-term use may increase the risk of cardiovascular diseases such as heart attack and stroke.
  • Gastrointestinal Issues: Some users experience persistent gastrointestinal problems like stomach ulcers, bleeding, and digestive issues.
  • Kidney Function: Prolonged use can lead to impaired kidney function, necessitating regular monitoring.
  • Immune System: Mounjaro can suppress the immune system, making users more susceptible to infections.
  • Mental Health: Mood changes, depression, and anxiety have been reported by some individuals.

It’s crucial to discuss these potential risks with your doctor to ensure that Mounjaro is the right medication for you and to manage any side effects effectively. If you have any specific concerns or symptoms, don’t hesitate to contact your doctor.

How Long Does Mounjaro Side Effects Last?

The duration of Mounjaro’s side effects can vary from person to person. For most individuals, common side effects such as nausea, vomiting, and diarrhea tend to be temporary, typically subsiding after the first few weeks of treatment. These effects occur as the body adjusts to the medication and often diminish as the digestive system becomes accustomed to Mounjaro’s action on blood sugar and digestion.

  • Nausea usually improves within the first 1-2 weeks, though some people may experience it for up to a month.
  • Diarrhea and vomiting also tend to lessen after the initial few weeks, with most cases resolving within the first month.
  • Decreased appetite can persist for longer, especially since this side effect contributes to the weight loss associated with Mounjaro. It may continue throughout treatment.
  • Abdominal pain often fades as the digestive system adapts, usually within a few weeks.

For more serious side effects like pancreatitis or allergic reactions, their duration depends on the severity and how quickly they are treated. Immediate medical attention is required in such cases to manage and reduce the risks. If any serious side effects occur, they should be addressed immediately to prevent long-lasting health issues.

In most cases, mild side effects are manageable and temporary, while the benefits of better blood sugar control and weight loss often outweigh these initial discomforts.

Who Should Not Use Mounjaro?

Certain individuals should avoid using Mounjaro due to the potential risks. Here are key contraindications:

  • History of Medullary Thyroid Cancer (MTC): Mounjaro should not be used by individuals or those with a family history of MTC. This is due to a potential link between the medication and an increased risk of thyroid tumors in animal studies.
  • Multiple Endocrine Neoplasia Syndrome Type 2 (MEN 2): People with this genetic condition should not take Mounjaro because of the same risks associated with thyroid cancer.
  • Allergies to Tirzepatide or Its Ingredients: Anyone with known allergies to tirzepatide or any inactive ingredients in the medication should avoid using Mounjaro.
  • Pregnancy and Breastfeeding: Mounjaro is not recommended for pregnant women or those planning to become pregnant due to potential risks to the fetus. It’s also unknown whether the drug passes into breast milk, so it’s important to avoid using Mounjaro while breastfeeding unless directed otherwise.

What Should You Do If You Experience Mounjaro Side Effects?

Monitoring side effects and how your body responds to Mounjaro is crucial for safely continuing the medication. Here’s what you can do:

  • Keep a Symptom Diary: Track any side effects you experience, including their frequency and intensity. Note when symptoms occur, how long they last, and any possible triggers. This can help identify patterns and better manage your symptoms.
  • Importance of Regular Health Check-ups: Routine check-ups are important while taking Mounjaro. Blood sugar levels, kidney function, and other key health markers should be regularly monitored to ensure the medication is working effectively and safely.
  • Report Side Effects: If you experience significant or persistent side effects, discuss them. While mild side effects often resolve on their own, serious symptoms (like those associated with pancreatitis or severe dehydration) require immediate attention.
Buy Mounjaro KwikPens from Canada

Starting from $499.97

Now Available: Mounjaro KwikPens

Choose BuyCanadianInsulin.com for affordable medications and take control of your health with reliable, cost-effective options today!

SAVE 10% with coupon code:

FIRST10

Conclusion

Understanding the potential side effects of Mounjaro is critical for anyone using it to manage type 2 diabetes. While most side effects are mild and temporary, some can be serious, requiring medical attention. By staying informed and monitoring your response to the medication, you can safely benefit from its ability to control blood sugar and promote weight loss. Regular check-ins with your doctor are key to managing any issues that may arise during treatment.

FAQs About Mounjaro Side Effects

Frequently Asked Questions

Hair loss is not a commonly observed side effect of Mounjaro. However, according to a clinical study conducted in 2022, 4.9% to 5.7% of individuals using a dosage of 5 mg to 15 mg of Mounjaro experienced hair loss (alopecia), compared to 0.9% of those using a placebo. If hair loss occurs, it is likely attributable to factors such as stress or nutritional deficiencies rather than the medication itself.
Yes, some patients have reported headaches while taking Mounjaro, particularly during the early weeks of treatment. This side effect often subsides as the body adjusts to the medication.
Yes, dizziness can occur in some people, especially if blood sugar levels drop too low (hypoglycemia). Monitoring blood sugar levels can help manage this side effect.
Fatigue is a less common side effect, but some individuals may experience it, particularly if they are also dealing with low blood sugar or dehydration.
Feeling cold is not a typical side effect of Mounjaro. If you experience this symptom, it may be related to other factors such as blood sugar fluctuations or weight loss.
Insomnia is not commonly associated with Mounjaro use. If sleep disturbances occur, they are likely unrelated to the medication.
Yes, most common side effects, such as nausea, vomiting, and diarrhea, tend to decrease over time as your body adjusts to the medication, usually within the first few weeks.
Yes, burping or increased belching may occur as a result of slowed digestion, which is one of the effects of Mounjaro. This side effect is typically mild and temporary.
Yes, constipation is a reported side effect. It occurs because Mounjaro slows down digestion. Increasing fiber intake and staying hydrated can help manage this.
Heartburn or acid reflux is not commonly reported, but it may happen in some individuals as Mounjaro affects how food moves through the digestive tract.
Body aches are not typically associated with Mounjaro. If you experience aches, they may be due to other factors such as dehydration or unrelated conditions.
To prevent side effects, follow the recommended dosing schedule and avoid eating large, fatty meals. Gradually increasing the dose under guidance can also help minimize side effects.
Depression is not a reported side effect of Mounjaro. If feelings of depression arise, they may be related to other health factors and should be monitored separately.
Dry mouth is not commonly reported with Mounjaro, but if you experience it, staying hydrated and chewing sugar-free gum may help alleviate the discomfort.
Mounjaro’s weight loss can be significant, but it is not guaranteed to be permanent. Maintaining weight loss depends on long-term lifestyle changes and medication.
Yes, Mounjaro can decrease appetite, leading to reduced food intake and weight loss. This effect is due to how the medication affects the digestive system and appetite hormones.
Dehydration can occur if you experience vomiting or diarrhea while on Mounjaro. It’s important to stay hydrated, especially if these side effects are present.
Blurred vision is not a common side effect of Mounjaro. However, fluctuations in blood sugar levels may lead to temporary vision changes, which should be monitored closely.

Sources

Eli Lilly and Company. (n.d.). How to use Mounjaro. Mounjaro. https://mounjaro.lilly.com/how-to-use-mounjaro

Cleveland Clinic. (2023, January 24). Mounjaro for weight loss: How Tirzepatide helps with diabetes and weight. https://health.clevelandclinic.org/mounjaro-for-weight-loss

National Center for Biotechnology Information. (2022). Tirzepatide. In Drugs and lactation database (LactMed). https://www.ncbi.nlm.nih.gov/books/NBK585056/

U.S. Food and Drug Administration. (2022). Mounjaro (tirzepatide) injection label. https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215866s000lbl.pdf

The University of Chicago Medicine. (2024, May). Research on GLP-1 drugs and their impact. https://www.uchicagomedicine.org/forefront/research-and-discoveries-articles/2024/may/research-on-glp-1-drugs

Frías, J. P., Davies, M. J., Rosenstock, J., Pérez Manghi, F. C., Fernández Landó, L., Bergman, B. K., Liu, B., Cui, X., & Brown, K. (2022). Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes. The New England Journal of Medicine, 387(6), 503–515. https://www.nejm.org/doi/full/10.1056/NEJMoa2206038

Rubino, D., Abrahamson, M. J., Dietz, B. G., Garrido, M. D., Grimaldi, A., Mingrone, G., … & Rosenstock, J. (2023). Tirzepatide versus placebo in adults with type 2 diabetes: A 40-week randomized controlled trial. JAMA, 330(4), 337–347. https://jamanetwork.com/journals/jama/fullarticle/2810542